CN110384785A - 一种用于治疗病毒性感冒的外用中药药液及其制备方法 - Google Patents
一种用于治疗病毒性感冒的外用中药药液及其制备方法 Download PDFInfo
- Publication number
- CN110384785A CN110384785A CN201910784592.3A CN201910784592A CN110384785A CN 110384785 A CN110384785 A CN 110384785A CN 201910784592 A CN201910784592 A CN 201910784592A CN 110384785 A CN110384785 A CN 110384785A
- Authority
- CN
- China
- Prior art keywords
- extracting solution
- medical fluid
- chinese medicine
- external application
- mulberry leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 105
- 239000012530 fluid Substances 0.000 title claims abstract description 67
- 241000700605 Viruses Species 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 39
- 240000000249 Morus alba Species 0.000 claims abstract description 37
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 37
- 240000000113 Baeckea frutescens Species 0.000 claims abstract description 36
- 235000004335 Baeckea frutescens Nutrition 0.000 claims abstract description 36
- 244000062245 Hedychium flavescens Species 0.000 claims abstract description 33
- 239000006286 aqueous extract Substances 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 239000000463 material Substances 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 23
- 238000010438 heat treatment Methods 0.000 claims description 22
- 238000001914 filtration Methods 0.000 claims description 13
- 241000501743 Gentiana macrophylla Species 0.000 claims description 6
- 238000001256 steam distillation Methods 0.000 claims description 6
- 206010022000 influenza Diseases 0.000 abstract description 56
- 206010037660 Pyrexia Diseases 0.000 abstract description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 22
- 201000010099 disease Diseases 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 10
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 10
- 230000000840 anti-viral effect Effects 0.000 abstract description 7
- 230000000857 drug effect Effects 0.000 abstract description 6
- 230000000202 analgesic effect Effects 0.000 abstract description 5
- 231100000614 poison Toxicity 0.000 abstract description 5
- 230000035876 healing Effects 0.000 abstract description 4
- 239000003440 toxic substance Substances 0.000 abstract description 4
- 230000017525 heat dissipation Effects 0.000 abstract description 3
- 239000006210 lotion Substances 0.000 abstract description 3
- 239000002674 ointment Substances 0.000 abstract description 3
- 238000001467 acupuncture Methods 0.000 abstract description 2
- 230000033228 biological regulation Effects 0.000 abstract description 2
- 238000004140 cleaning Methods 0.000 abstract description 2
- 230000001151 other effect Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 75
- 230000000694 effects Effects 0.000 description 35
- 229940079593 drug Drugs 0.000 description 27
- 208000024891 symptom Diseases 0.000 description 22
- 206010011224 Cough Diseases 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 206010019233 Headaches Diseases 0.000 description 10
- 230000036760 body temperature Effects 0.000 description 10
- 231100000869 headache Toxicity 0.000 description 10
- 208000002173 dizziness Diseases 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000009991 scouring Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 201000009240 nasopharyngitis Diseases 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 230000001754 anti-pyretic effect Effects 0.000 description 5
- 239000002221 antipyretic Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 206010063659 Aversion Diseases 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 229940109262 curcumin Drugs 0.000 description 4
- 239000004148 curcumin Substances 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000712461 unidentified influenza virus Species 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010061876 Obstruction Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000036071 Rhinorrhea Diseases 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 235000012754 curcumin Nutrition 0.000 description 3
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 208000013433 lightheadedness Diseases 0.000 description 3
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- -1 nasosinusitis Diseases 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- FEPANGQIGHBDFZ-UHFFFAOYSA-N 1-(2-hydroxy-4,6-dimethoxy-3-methylphenyl)-2-methylpropan-1-one Chemical compound COC1=CC(OC)=C(C(=O)C(C)C)C(O)=C1C FEPANGQIGHBDFZ-UHFFFAOYSA-N 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241001115458 Carphophis Species 0.000 description 2
- 206010008531 Chills Diseases 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 102400000739 Corticotropin Human genes 0.000 description 2
- 101800000414 Corticotropin Proteins 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000004360 Dioscorea zingiberensis Nutrition 0.000 description 2
- 241001678283 Dioscorea zingiberensis Species 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 241001071804 Gentianaceae Species 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000008017 Hypohidrosis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- 235000005018 Pinus echinata Nutrition 0.000 description 2
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 2
- 235000016013 Pinus leiophylla var chihuahuana Nutrition 0.000 description 2
- 240000007320 Pinus strobus Species 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000010231 banlangen Substances 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 2
- 229960000258 corticotropin Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- DFNZYFAJQPLJFI-UHFFFAOYSA-N gentianine Chemical group O=C1OCCC2=C1C=NC=C2C=C DFNZYFAJQPLJFI-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 235000013490 limbo Nutrition 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000510654 Bupleurum chinense Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241000967672 Gentiana crassicaulis Species 0.000 description 1
- 241000501719 Gentiana straminea Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010071699 Infectious pleural effusion Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 241000244269 Peucedanum Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039740 Screaming Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 1
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229960003971 influenza vaccine Drugs 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N methyl phenyl ether Natural products COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- ZDPHROOEEOARMN-UHFFFAOYSA-N n-hendecanoic acid Natural products CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000031942 natural killer cell mediated cytotoxicity Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 208000008494 pericarditis Diseases 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- RBNWAMSGVWEHFP-UHFFFAOYSA-N trans-p-Menthane-1,8-diol Chemical compound CC(C)(O)C1CCC(C)(O)CC1 RBNWAMSGVWEHFP-UHFFFAOYSA-N 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 208000025301 tympanitis Diseases 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药技术领域,具体涉及一种用于治疗病毒性感冒的外用中药药液及其制备方法,包括以下重量百分比含量的原料:桂枝提取液58‑60%;岗松提取液18‑22%;柴胡提取液5‑7%;黄姜提取液3‑5%;秦艽提取液3‑4%;桑叶水提液余量。本发明制备得到的药液具有抗菌消炎、抗病毒、解毒散热、驱风止痛、快速退烧等功效,对流感病毒具有抑制作用,用于病毒性感冒,见效快、疗效显著。而且通过用药液擦洗全身或在穴位处擦药,内病外治,调和气血,通络除湿,祛风散热,使药效药效渗透皮肤深入全身发挥作用,能够起到迅速退烧消除病毒,达到治愈的目的。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种用于治疗病毒性感冒的外用中药药液及其制备方法。
背景技术
感冒,是由多种病毒引起的一种呼吸道常见病,总体分为普通感冒和流行感冒。平常所说的都是普通感冒,俗称伤风。感冒大多在人们着凉后引起,开始有鼻咽部干、痒、灼热感,继而出现喷嚏、鼻塞、鼻流清涕、流眼泪等症状。1-2天后可伴有咽痛、咳嗽、或有发热、头痛、全身酸痛、食欲减退,或有恶心呕吐、腹泻等症状。感冒70%~80%是由病毒感染引起,少部分由细菌感染所致。感冒危害着人类的健康,它可降低人体的免疫能力,引起其他疾病,如咽喉炎、鼻窦炎、中耳炎、支气管炎和肺炎,甚至脓胸、肝脓肿、心包炎和骨髓炎等。由于目前尚无确切的抗病原体药物,所以西药对感冒的治疗主要是缓解症状,防止继发感染。临床应用的抗感冒药已有几十种,它们对于感冒所引起的各种症状具有缓解或消除作用,但最终还需靠人的自身免疫力治愈,且一般都有嗜唾、困倦等副作用。
流感是由流感病毒引发的一种比普通感冒更为严重的急性呼吸道传染病,其特点为起病急、传染性强、发病率高、病程长。目前防治流感的最有效手段是接种流感疫苗,但由于流感病毒变异性强,可使现有疫苗失效,从而加大了防治的难度。目前,治疗感冒的药物有很多种类,有西药片剂、西药针剂、中药水剂、中药片、中药丸、中药提取物针剂等。片剂在生产中需加入若干辅料并压缩成型,存在这溶出度低、生物利用度差、小儿和昏迷病人不能吞服以及储存过程中片剂容易变硬、崩解时间延长等缺点;大多数口服药(包括中药丸、片剂、水剂、西药片剂、水剂等)也都存在药物吸收通过胃肠、肝脏进入人体内循环,在吸收过程中易受胃酸破坏及粘膜中酶、肝内药物代谢酶等作用造成药物损失,致使疗效降低、药物及其代谢产物由肝(胆汁)、肾排泄,给肝、肾、血液带来一定负担和不利影响,还会不同程度抑制神经中枢,引起头晕、困倦、恶心、呕吐、乏力等症状,有的还会导致过敏反应。针剂给药的缺点是制造工艺复杂、成本高,而且当药物的分子量大时,肌注易造成毛细管血管壁吸收慢,致使疗效降低,易引起心悸、心律失常、血压降低、惊厥等不良反应,小儿注射也因哭闹而难以操作,另外针剂生产成本高,也需要一定的技术和条件操作,病人不能自己使用;而且针剂给药,虽然见效很快,但是副作用也大,使用次数多的话很容易产生耐药性,危害患者身体健康,尤其对于儿童患者,更不能轻易使用。
从中医的角度讲,感冒、流感是在机体内火伏里的基础上外感风寒引发的。中药治疗感冒既可清除内热,又可疏散外表风寒之邪,表里同治,并且中药可以整体调节人体的免疫机能,达到扶正驱邪的目的,可以使感冒、流感得到彻底有效的治疗。临床上已有数十种治疗感冒的中成药问世,如板蓝根颗粒、抗病毒口服液、荆防败毒散等,但由于它们的药物组成较为单一,适应症比较局限,加上制剂工艺比较落后,起效较慢,而且大多数口服药在吸收过程中易受胃酸破坏及粘膜中酶、肝内药物代谢酶等作用造成药物损失,致使疗效降低,临床疗效不太理想。因此,研究开发出疗效显著、毒副作用低的防治感冒、流感产品,具有重要的意义。
发明内容
本发明的目的在于针对现有技术的不足,提供一种用于治疗病毒性感冒的外用中药药液及其制备方法,该药物具有抗菌消炎、抗病毒、解毒散热、驱风止痛、快速退烧等功效,无毒副作用,对流感病毒具有抑制作用,适用于治疗流行性病毒流感、恶寒发热、四肢无力、咽痛、热势起伏或往来寒热,头痛,不明原因的高低烧,全身不适等病症,作用效果显著。
为实现上述目的,本发明采用如下技术方案:
一种用于治疗病毒性感冒的外用中药药液,包括以下重量百分比含量的原料:桂枝提取液58-60%;岗松提取液18-22%;柴胡提取液5-7%;黄姜提取液3-5%;秦艽提取液3-4%;桑叶水提液 余量。
进一步的,所述的用于治疗病毒性感冒的外用中药药液,包括以下重量百分比含量的原料:桂枝提取液60%;岗松提取液20%;柴胡提取液7%;黄姜提取液4%;秦艽提取液4%;桑叶水提液 5%。
上述用于治疗病毒性感冒的外用中药药液,其制备方法包括如下步骤:
(1)分别取干燥的桂枝和岗松枝叶粉碎备用,分别加入药材总重量10~12 倍量的水,先浸泡2~3小时,然后水蒸气蒸馏提取2-3小时,得到馏出液,过滤,即得桂枝提取液和岗松提取液;
(2)分别取干燥的柴胡和秦艽药材进行粉碎,然后分别加入药材质量7-8倍量的水,加热煮沸40-45分钟,过滤,放出药液,药渣加6~7倍量的水加热重煮45-50分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到柴胡提取液和秦艽提取液;
(3)取黄姜和桑叶药材,分别加入药材质量10-12倍量的水,加热煮沸55-60分钟,过滤,放出药液,药渣加8~9倍量的水加热重煮45-50分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到黄姜提取液和桑叶水提液;
(4)将桂枝提取液、岗松提取液、柴胡提取液、黄姜提取液、秦艽提取液以及桑叶水提液按照重量百分比比例混合均匀即可得到用于治疗病毒性感冒的外用中药药液。
本发明所用的各味中药的药性如下:
桂枝为樟科植物肉桂 Cinnamomum cassia Presl的干燥嫩枝,主产于广西、广东及云南等地。春、夏季剪下嫩枝,晒干或阴干,切成薄片或小段用。桂枝辛温,可祛风寒,能治疗感冒风寒、发热恶寒等。性味归经:辛、甘,温,入肺、心、膀胱经。功效:发汗解肌,温通经脉,助阳化气。【药理作用】扩张血管、促进发汗、解热、镇痛、镇静、抗惊厥,抗菌、抗病毒。本发明中将桂枝经水蒸气蒸镏能得到肉桂油。桂枝煎剂有降温、解热作用,煎剂及醇浸也对金黄色葡萄球菌、伤寒杆菌、流感病毒等均有抑制作用;所含挥发油能刺激汗腺、扩张血管,还能利尿、强心、止咳、祛痰等;所含桂皮醛有镇痛、镇静、抗惊厥作用。肉桂具有抗真菌,抗菌,抗病毒和抗菌性能,能有效治疗外部以及内部感染,有助于破坏细菌在胆囊和金黄色葡萄球菌感染的细菌。
岗松,为桃金娘科植物岗松Baeckea frutescens L.的枝叶,分布江西、福建、广东、海南、广西等地。具有化瘀止痛,清热解毒,利尿通淋,杀虫止痒之功效,用于跌打瘀肿,肝硬化,热泻,热淋,小便不利,阴痒,脚气,湿疹,皮肤瘙痒,疥癣,水火烫伤,虫蛇咬伤。岗松叶含挥发油0.9~1.8%,其中α-蒎烯和β-蒎烯占58%,对聚伞花素0.7%,1,8-桉叶素7.4%,柠檬烯和二戊烯共3.1%,芳樟醇、小茴香醇、龙脑和松油醇共10%,倍半萜烯1.4%,倍半萜烯醇3%,酚类2.4%,结晶的酚醚5.5%。此外,还含岗松醇。从岗松枝叶中提取得到的岗松油是一种高级杀菌药用油,具有化瘀止痛、清热解毒、利尿通淋、杀虫止痒之功效。用于跌打瘀肿、肝硬化、热泻、热淋、小便不利、脚气、皮肤瘙痒、疥癣、水火烫伤、虫蛇咬伤。
柴胡,为伞形科植物柴胡Bupleurum chinense DC.或狭叶柴胡Bupleurum scorzonerifolium Willd.的干燥根。性味归经:性微寒、味苦、辛、归肝经、胆经,具疏肝利胆、疏气解郁、散火之功效。功能主治:透表泄热,疏肝解郁,升举阳气。清虚热中药,用于感冒发热、寒热往来、疟疾、肝郁气滞、胸肋胀痛、脱肛、子宫脱落、月经不调。柴胡其成分主要含柴胡皂苷(saikosapoins a、 b、 c、 d 四种),甾醇,挥发油(柴胡醇、丁香酚等),脂肪酸(油酸、亚麻油酸、棕榈酸、硬脂酸等)和多糖等。药理功用:1、解热,有效成分:挥发油(丁香酚、已酸、r-十一酸内酯和对甲氧基苯二酮),柴胡皂苷(皂苷元A)。作用:对伤寒、副伤寒疫苗、大肠杆菌液、发酵牛奶、酵母等所致发热有明显解热作用;且能使动物正常体温下降。2.抗炎,有效成分:皂苷。作用:对多种致炎剂所致踝关节肿和结缔组织增生性炎症均有抑制作用。3.促进免疫功能,有效成分:柴胡多糖。作用:吞噬功能增强、自然杀伤细胞功能增强,提高病毒特异性抗体滴度,提高淋巴细胞转核率,提高皮肤迟发性过敏反应。4.抗肝损伤5.抗辐射损伤。
黄姜又叫盾叶薯蓣、火头根,拉丁学名:Dioscorea zingiberensis C. H. Wright. 黄姜有解毒消肿、清肺止咳、利湿通淋、通络止痛的功效,可以用于治疗风湿腰痛、肺热咳嗽、痈肿恶疮,跌打扭伤、痈疖早期未破溃、皮肤急性化脓性感染、软组织损伤以及蜂蜇虫咬等。姜黄提取物、姜黄素、挥发油、姜黄酮以及姜烯、龙脑和倍半萜醇等,都有利胆作用,能增加胆汁的生成和分泌,并能促进胆囊收缩,而以姜黄素的作用为最强。姜黄素及挥发油部分对金黄色葡萄球菌有较好的抗菌作用。黄姜中的主要成分—姜黄素,具有抗氧化、抗肿瘤、降血脂、降血糖、抗溃疡、保护肝脏、抗心肌缺血、抗抑郁、抗菌、消炎、抗病毒和抗真菌等作用,可用于治疗癌症、糖尿病、冠心病、关节炎、阿尔茨海默氏病(早老性痴呆)以及其他慢性疾病。
秦艽,为龙胆科植物秦艽Gentiana macrophylla Pall.、麻花秦艽Gentiana straminea Maxim.、粗茎秦艽Gentiana crassicaulis Duthie ex Burk.或小秦艽Gentiana dahurica Fisch. 的干燥根。功能主治:祛风除湿,和血舒筋,清热利尿,治风湿痹痛,筋骨拘挛,黄疸,便血,骨蒸潮热,小儿疳热,小便不利;是治疗风湿关节痛、结核病、潮热、黄疸等症的主药之一。药理作用:1、抗炎:能抑制实验性关节炎,有效成分为秦艽甲素。抗炎原理是通过神经系统间接刺激垂体,使促皮质素分泌增加,肾上腺皮质功能亢进,从而有助于消炎消肿。2、解热:前人说秦艽能治潮热,现代实验证明,秦艽确有解热作用。3、镇痛和镇静。动物实验证明,本品有一定镇痛和镇静作用。4、抗过敏:有一定抗组织胺和抗过敏性休克的作用。5、升血糖:有效成分为秦艽甲素,可能是通过释放肾上腺素而起作用。6、降压:其水浸液等有降低麻醉动物血压的作用。7、抗菌:对痢疾杆菌、伤寒杆菌、金黄色葡萄菌等有抑菌作用。
桑叶,为桑科植物桑Morus alba L. 的干燥叶。功能主治:疏散风热,清肺润燥,清肝明目。用于风热感冒,肺热燥咳,头晕头痛,目赤昏花。桑叶具有抗菌消炎、清热解毒之功效。桑叶中含有的DNJ矿物质,能润肠通便、改善便秘,有效地缓解体内毒素堆积现象。桑叶善于散风热而泄肺热,对外感风热、头痛、咳嗽等,常与菊花、银花、薄荷、前胡、桔梗等配合应用。桑叶不仅可用于风热引起的目赤羞明,且可清肝火,对肝火上炎的目赤肿痛,可与菊花、决明子、车前子等配合应用。桑叶轻清发散,能散风热,但作用较弱。临床主要用于清泄肺肝,如风热袭肺、咳嗽多痰,或燥热伤肺、干咳无痰;以及风热上攻或肝火上炎、目赤肿痛等症,为常用的药品。现代中、西医把桑叶和桑叶生物制剂作为改善糖尿病及其他各种疑难杂症的药物而使用,认为其药效极为广泛。有清肺润燥、止咳、去热、化痰、治盗汗;补肝、清肝明目、治疗头晕眼花、失眠、消除眼部疲劳;消肿、清血'治疗痢疾、腹痛、减肥、除脚气、利大、小肠;抗应激、凉血、降血压、降血脂、预防心肌梗塞、脑溢血、祛头痛、长发;降血糖、抗糖病等。
本发明的中药配伍原理如下:
本发明制备的治疗病毒性感冒的外用中药药液方中采用了桂枝、岗松、柴胡、黄姜、秦艽以及桑叶,方中以桂枝为君药,能祛风寒、发汗解肌,温通经脉、抑制流感病毒。岗松为臣药,助君药清热解毒、杀菌止痛,柴胡和秦艽透表泄热,解热、祛风除湿,疏肝利胆,清热利尿,黄姜和桑叶抗菌消炎、清热解毒、疏散风热,清肺润燥,通络止痛;诸药合用共奏通络除湿,祛风散热、调和气血,清热解毒之效。本发明综合起来利用了各味药的功效,通过外用的形式,从人体皮肤渗透下去,通过血液循环,进入腑脏,通过药物作用达到清热解毒,发汗解热、抗菌消炎、通络止痛、祛风散寒等作用,能够迅速退烧消除病毒,达到治愈的目的。
本发明制备得到的用于治疗病毒性感冒的外用中药药液适用于流行性病毒流感、恶寒发热、四肢无力、咽痛、热势起伏或往来寒热,头痛,无汗或少汗、鼻塞、咳嗽、头昏目眩,心烦呕吐,纳呆,面红耳赤,不明原因的高低烧,全身不适等病症。其使用方法为:外用,每次50毫升;用50℃温水泡暖本品,用小毛巾或纱布擦洗全身,多擦洗大椎穴、头部、胸部、腰部、背部及手脚,擦洗10分钟后多擦脚底5分钟即可,男女老少皆宜,每日早晚擦洗两次;儿童每次用30毫升,每日三次。
本发明的有益效果为:
1、本发明所用的原料药材来源广,成本低,而且生产方法简单,制备得到的药液具有抗菌消炎、抗病毒、解毒散热、驱风止痛、快速退烧等功效,对流感病毒具有抑制作用,用于病毒性感冒,见效快、而且疗效显著,无副作用。
2、本发明制备得到的治疗病毒性感冒的外用中药药液通过内病外治的方式,通过皮肤吸收不会给内脏带来副作用,也不会如口服药那样在吸收过程中易产生药物损失的情况,男女老少皆宜,特别适合小孩使用,解决了服药困难的问题。而且见效快,对于一般的感冒发烧症状,在擦完药之后两小时内就能有效退烧,疗效显著。
3、本发明治疗病毒性感冒的外用中药药液是发明人潜心研究多年、开发的专门用于解毒散热、驱风止痛、治疗流行性病毒流感、恶寒发热、四肢无力、咽痛、热势起伏或往来寒热,头痛,腰痛、无汗或少汗、鼻塞、咳嗽、头昏目眩,心烦呕吐,纳呆,面红耳赤,不明原因的高低烧,全身不适等病症的药液。通过用药液擦洗全身或在穴位处擦药,内病外治,调和气血,通络除湿,祛风散热、清热解毒、扶正驱邪,通过揉擦使药效药效渗透皮肤深入全身发挥作用,能够起到迅速退烧消除病毒,达到治愈的目的。
4、本发明所采用的桂枝、岗松、黄姜等植物都是广西桂南地区大容山区的宝贵药材,可以开发治疗皮炎、湿疹、红眼病和流感等疾病的药物,本发明人莫兆钦是广西源安堂制药公司的技术人员,他利用独特地理位置----大容山腹地丰富的中草药资源,开辟当地丰富药材资源,这些年开发研究了“肤阴洁(黄松洗液)”、并获得了许多国家发明专利,如“治疗皮肤瘙痒的药膏及其制备方法,201410719136.8”、“一种治疗风湿痹痛和急性扭挫伤症的外用酊剂药物及其制备方法 -200810073697.X”、“一种治疗风热感冒的中药口服液及其制备方法 -200810073696.5”、 “感冒脐疗中药制剂及其生产方法,00131124.7 ”、“ 玉桂茶及其生产方法,201310609359.4”、“ 一种治疗阴道炎的复方黄松凝胶药物及其制备方法,201210118059.1”,治疗了很多西医无法医治的疑难杂症,获得了广西医药界的很多名誉,在利用民族医药、扶贫开发等方面作出很大的贡献。本发明治疗病毒性感冒的外用中药药液则是莫兆钦过去几十年在研究和开发广西少数民族医药的一个新的起点。
具体实施方式
实施例1
一种用于治疗病毒性感冒的外用中药药液,包括以下重量百分比含量的原料:桂枝提取液58%;岗松提取液22%;柴胡提取液5%;黄姜提取液5%;秦艽提取液3%;桑叶水提液 7%;
所述用于治疗病毒性感冒的外用中药药液,其制备方法包括如下步骤:
(1)分别取干燥的桂枝和岗松枝叶粉碎备用,分别加入药材总重量10倍量的水,先浸泡2小时,然后水蒸气蒸馏提取2小时,得到馏出液,过滤,即得桂枝提取液和岗松提取液;
(2)分别取干燥的柴胡和秦艽药材进行粉碎,然后分别加入药材质量7倍量的水,加热煮沸40分钟,过滤,放出药液,药渣加6倍量的水加热重煮45分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到柴胡提取液和秦艽提取液;
(3)取黄姜和桑叶药材,分别加入药材质量10倍量的水,加热煮沸55分钟,过滤,放出药液,药渣加8倍量的水加热重煮45分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到黄姜提取液和桑叶水提液;
(4)将桂枝提取液、岗松提取液、柴胡提取液、黄姜提取液、秦艽提取液以及桑叶水提液按照重量百分比比例混合均匀即可得到用于治疗病毒性感冒的外用中药药液。
实施例2
一种用于治疗病毒性感冒的外用中药药液,包括以下重量百分比含量的原料:桂枝提取液60%;岗松提取液20%;柴胡提取液7%;黄姜提取液4%;秦艽提取液4%;桑叶水提液 5%;
所述用于治疗病毒性感冒的外用中药药液,其制备方法包括如下步骤:
(1)分别取干燥的桂枝和岗松枝叶粉碎备用,分别加入药材总重量11 倍量的水,先浸泡2.5小时,然后水蒸气蒸馏提取2.5小时,得到馏出液,过滤,即得桂枝提取液和岗松提取液;
(2)分别取干燥的柴胡和秦艽药材进行粉碎,然后分别加入药材质量7.5倍量的水,加热煮沸43分钟,过滤,放出药液,药渣加6~7倍量的水加热重煮45分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到柴胡提取液和秦艽提取液;
(3)取黄姜和桑叶药材,分别加入药材质量11倍量的水,加热煮沸58分钟,过滤,放出药液,药渣加8.5倍量的水加热重煮47分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到黄姜提取液和桑叶水提液;
(4)将桂枝提取液、岗松提取液、柴胡提取液、黄姜提取液、秦艽提取液以及桑叶水提液按照重量百分比比例混合均匀即可得到用于治疗病毒性感冒的外用中药药液。
实施例3
一种用于治疗病毒性感冒的外用中药药液,包括以下重量百分比含量的原料:桂枝提取液59%;岗松提取液18%;柴胡提取液7%;黄姜提取液3%;秦艽提取液4%;桑叶水提液 9%;
所述用于治疗病毒性感冒的外用中药药液,其制备方法包括如下步骤:
(1)分别取干燥的桂枝和岗松枝叶粉碎备用,分别加入药材总重量12 倍量的水,先浸泡3小时,然后水蒸气蒸馏提取3小时,得到馏出液,过滤,即得桂枝提取液和岗松提取液;
(2)分别取干燥的柴胡和秦艽药材进行粉碎,然后分别加入药材质量8倍量的水,加热煮沸45分钟,过滤,放出药液,药渣加7倍量的水加热重煮50分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到柴胡提取液和秦艽提取液;
(3)取黄姜和桑叶药材,分别加入药材质量12倍量的水,加热煮沸60分钟,过滤,放出药液,药渣加9倍量的水加热重煮50分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到黄姜提取液和桑叶水提液;
(4)将桂枝提取液、岗松提取液、柴胡提取液、黄姜提取液、秦艽提取液以及桑叶水提液按照重量百分比比例混合均匀即可得到用于治疗病毒性感冒的外用中药药液。
实施例4
一种用于治疗病毒性感冒的外用中药药液,包括以下重量百分比含量的原料:桂枝提取液60%;岗松提取液22%;柴胡提取液6%;黄姜提取液5%;秦艽提取液3.5%;桑叶水提液3.5%;
所述用于治疗病毒性感冒的外用中药药液,其制备方法包括如下步骤:
(1)分别取干燥的桂枝和岗松枝叶粉碎备用,分别加入药材总重量10倍量的水,先浸泡3小时,然后水蒸气蒸馏提取2.5小时,得到馏出液,过滤,即得桂枝提取液和岗松提取液;
(2)分别取干燥的柴胡和秦艽药材进行粉碎,然后分别加入药材质量7倍量的水,加热煮沸45分钟,过滤,放出药液,药渣加6倍量的水加热重煮48分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到柴胡提取液和秦艽提取液;
(3)取黄姜和桑叶药材,分别加入药材质量11倍量的水,加热煮沸57分钟,过滤,放出药液,药渣加8.5倍量的水加热重煮48分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到黄姜提取液和桑叶水提液;
(4)将桂枝提取液、岗松提取液、柴胡提取液、黄姜提取液、秦艽提取液以及桑叶水提液按照重量百分比比例混合均匀即可得到用于治疗病毒性感冒的外用中药药液。
资料
1、诊断标准
确诊为病毒性感冒的患者症状为:急性发病,高热,畏寒,头痛头晕,全身关节肌肉酸痛,乏力等流感症状。可伴有咽痛,流涕,流泪,咳嗽等呼吸道症状;少数病例有食欲减退,伴有腹痛,腹胀腹泻和呕吐等消化道症状。
2、对符合上标准的入选病例,发病后均未自行服用抗病毒、解热镇痛类药物,排除哺乳期妇女或有其他重大疾病的患者,共计168例患者入选本试验,其中男性81例,女性87例,年龄3-68岁,病程4小时-48小时。
3、治疗方案
使用本发明实施例2制备得到的外用中药药液,使用方法为:外用,用50℃温水泡暖本品,用小毛巾或纱布擦洗全身,多擦洗大椎穴、头部、胸部、腰部、背部及手脚,擦洗10分钟后多擦脚底5分钟即可,成人每次50毫升,每日早晚擦洗两次;儿童每次用30毫升,每日三次;3天为一疗程,疗程中了解并记录患者症状的改变情况(至少1天1次)。
4、疗效标准
疗效标准 参考《中医新药临床研究指南原则》感冒疗效标准:
①治愈:治疗3天以内体温恢复正常,临床症状、体征消失或基本消失,症状积分减少≧95%;②有效:治疗3天以内体温有所降低,临床症状、体征好转,症状积分减少≧30%;③无效:治疗3天以内体温未见明显变化,临床症状、体征无改善甚至加重,症状积分减少不足30%。
5、治疗结果
治疗3天后,130例患者中治愈153例,有效9例,无效6例,总有效率96.4%。
6、结论
上述可见,本发明用于治疗病毒性感冒的外用中药药液治疗病毒性感冒疗效显著,可显著改善咽痛、头痛,鼻塞、咳嗽、头昏目眩,流涕、恶寒、发热、全身不适酸痛等症状,疗效确切,而且见效快,对于能够病毒性感冒引起的体温升高发烧的症状,在使用了本发明的药液后能够起到迅速退烧使体温恢复正常的作用,安全无毒副作用,总有效率高。
7、典型病例
病例1
赵某,女,3岁,咳嗽、喉咙痛,食欲下降、情绪烦躁,精神不佳,发热6小时,体温38.4℃,采用本发明实施例2制备得到的外用中药药液进行擦洗全身,两小时后,体温得到下降,逐渐趋于正常(37±0.2℃),使用本发明药液一个疗程后感冒症状消除,临床症状消失,感冒痊愈。
病例2
周某某,男,42岁,头痛头晕,全身无力,畏寒,咽痛,伴发热1天,体温38.7℃,采用本发明实施例2制备得到的外用中药药液进行擦洗全身,擦洗后,体温逐渐下降趋于正常(37±0.2℃),使用本发明药液一天后感冒头疼症状逐渐消失,精神状态变好,使用本发明药液一个疗程后感冒症状消除,临床症状消失,感冒痊愈。
病例3
王某,男,61岁,流涕、喷嚏、咽痛、发热、病程2天,体温37.8℃,采用本发明实施例2制备得到的外用中药药液进行擦洗全身,擦洗后,体温逐渐下降趋于正常(37±0.2℃),使用本发明药液一个疗程后感冒症状消除,临床症状消失,感冒痊愈。
Claims (3)
1.一种用于治疗病毒性感冒的外用中药药液,其特征在于,包括以下重量百分比含量的原料:桂枝提取液58-60%;岗松提取液18-22%;柴胡提取液5-7%;黄姜提取液3-5%;秦艽提取液3-4%;桑叶水提液 余量。
2.根据权利要求1所述的用于治疗病毒性感冒的外用中药药液,其特征在于,包括以下重量百分比含量的原料:桂枝提取液60%;岗松提取液20%;柴胡提取液7%;黄姜提取液4%;秦艽提取液4%;桑叶水提液 5%。
3.根据权利要求1或2所述的用于治疗病毒性感冒的外用中药药液,其特征在于,其制备方法包括如下步骤:
(1)分别取干燥的桂枝和岗松枝叶粉碎备用,分别加入药材总重量10~12 倍量的水,先浸泡2~3小时,然后水蒸气蒸馏提取2-3小时,得到馏出液,过滤,即得桂枝提取液和岗松提取液;
(2)分别取干燥的柴胡和秦艽药材进行粉碎,然后分别加入药材质量7-8倍量的水,加热煮沸40-45分钟,过滤,放出药液,药渣加6~7倍量的水加热重煮45-50分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到柴胡提取液和秦艽提取液;
(3)取黄姜和桑叶药材,分别加入药材质量10-12倍量的水,加热煮沸55-60分钟,过滤,放出药液,药渣加8~9倍量的水加热重煮45-50分钟,药渣放出,过滤药液,合并得到的两次药液;分别得到黄姜提取液和桑叶水提液;
(4)将桂枝提取液、岗松提取液、柴胡提取液、黄姜提取液、秦艽提取液以及桑叶水提液按照重量百分比比例混合均匀即可得到用于治疗病毒性感冒的外用中药药液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910784592.3A CN110384785B (zh) | 2019-08-23 | 2019-08-23 | 一种用于治疗病毒性感冒的外用中药药液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910784592.3A CN110384785B (zh) | 2019-08-23 | 2019-08-23 | 一种用于治疗病毒性感冒的外用中药药液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110384785A true CN110384785A (zh) | 2019-10-29 |
CN110384785B CN110384785B (zh) | 2022-03-22 |
Family
ID=68289332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910784592.3A Active CN110384785B (zh) | 2019-08-23 | 2019-08-23 | 一种用于治疗病毒性感冒的外用中药药液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110384785B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112168928A (zh) * | 2020-08-23 | 2021-01-05 | 莫兆钦 | 一种中草药感冒退烧凝胶贴的应用与制备 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579588A (zh) * | 2012-03-28 | 2012-07-18 | 张继成 | 清热解表胶囊 |
CN107595946A (zh) * | 2017-09-27 | 2018-01-19 | 步新源 | 一种熏蒸治疗感冒的中药组合物及方法 |
CN109106777A (zh) * | 2018-10-30 | 2019-01-01 | 沈敬国 | 艾柱组合 |
-
2019
- 2019-08-23 CN CN201910784592.3A patent/CN110384785B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579588A (zh) * | 2012-03-28 | 2012-07-18 | 张继成 | 清热解表胶囊 |
CN107595946A (zh) * | 2017-09-27 | 2018-01-19 | 步新源 | 一种熏蒸治疗感冒的中药组合物及方法 |
CN109106777A (zh) * | 2018-10-30 | 2019-01-01 | 沈敬国 | 艾柱组合 |
Non-Patent Citations (1)
Title |
---|
东盟频道: "兆安堂病毒感冒舒创新引领内病外治潮流", 《HTTPS://WWW.SOHU.COM/A/325758895_100133314,兆安堂病毒感冒舒创新引领内病外治潮流》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112168928A (zh) * | 2020-08-23 | 2021-01-05 | 莫兆钦 | 一种中草药感冒退烧凝胶贴的应用与制备 |
Also Published As
Publication number | Publication date |
---|---|
CN110384785B (zh) | 2022-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104288701A (zh) | 一种治疗胆囊炎的中药组合物 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN102772712B (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
CN104258278A (zh) | 骨伤灵喷雾剂 | |
CN106806758A (zh) | 一种治疗痤疮的中药制剂 | |
CN104147538A (zh) | 一种治疗湿热毒盛型糖尿病足的中药制剂及其制备方法 | |
CN101249186A (zh) | 一种兼治外伤、风湿痛、牙痛的中药油剂及其生产方法 | |
CN110384785A (zh) | 一种用于治疗病毒性感冒的外用中药药液及其制备方法 | |
KR100712659B1 (ko) | 당뇨병 및 이로 인한 합병증 치료 및 예방용 한약조성물 | |
CN103721138A (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
CN107582702A (zh) | 用于中医蜡疗的药蜡组合物及其制备方法 | |
CN105561270A (zh) | 一种外敷止痛中草药及其制备方法 | |
CN105031487A (zh) | 一种治疗湿困脾胃型小儿黄疸的中药组合物 | |
CN104666799A (zh) | 软组织损伤活血化瘀药酒及制备方法 | |
CN105687962A (zh) | 治疗冠状动脉粥样硬化的冲剂及制备方法 | |
CN105056073A (zh) | 医治心律失常的中药制剂及制备方法 | |
CN106075180A (zh) | 一种治疗椎管内麻醉术后尿潴留的中药及其制备方法 | |
CN105943639A (zh) | 一种辅助治疗慢性硬脑膜下血肿的中药组合物 | |
CN105535853A (zh) | 一种临床护理上用于治疗褥疮的中药组合物 | |
CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN104225506A (zh) | 用于治疗化疗后血小板减少的药物制剂 | |
CN104997949A (zh) | 一种治疗鼻炎的中药组合物及其制备方法 | |
CN104435232B (zh) | 一种用于治疗牙痛的中药组合物 | |
CN104189313A (zh) | 一种用于治疗鲫鱼鱼怪病的药物组合物及其制备方法 | |
CN103933359A (zh) | 用于祛除瘢痕疙瘩的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |